FDA inspection
Regeneron Pharmaceuticals, Inc.: FDA inspection ending Jan 16, 2026
FDA inspection 1291552 · East Greenbush, NY
Key facts
| Inspection ID | 1291552 |
|---|---|
| Firm | Regeneron Pharmaceuticals, Inc. |
| FEI number | 3015581066 |
| Address | 350 Tempel Lane |
| City | East Greenbush |
| State | NY |
| ZIP | 12061 |
| Fiscal year | 2026 |
| Inspection end date | Jan 16, 2026 |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data